awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33726030-5981CFDD-B4B2-4635-BB2A-612C8FD910A7
Q33726030-5981CFDD-B4B2-4635-BB2A-612C8FD910A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33726030-5981CFDD-B4B2-4635-BB2A-612C8FD910A7
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents.
P2860
Q33726030-5981CFDD-B4B2-4635-BB2A-612C8FD910A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33726030-5981CFDD-B4B2-4635-BB2A-612C8FD910A7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e74e6b66a88d4eec17cf9fe51b2e9cabe2f07cad
P2860
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study